FDA Approved: VONJO — Supplemental Application (Sobi, Inc.)

View source ↗

Summary

FDA approved a Supplemental Application for Vonjo (pacritinib) from Sobi, Inc., updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• VONJO (pacritinib)

Snippet

SUPPL AP for VONJO (PACRITINIB)